The predictor(s) of response (CR, PR, and NR) to radiotherapy in HNSCC patients were determined by examining the patient's demographic, clinicopathological characteristics, and CD44 expression using univariate and multivariate ordinal logistic regression analyses. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.